57894-0503
Darzalex Faspro
Daratumumab and hyaluronidase-fihj (human recombinant)
INJECTION
Subcutaneous
DARATUMUMAB
1800.0
mg/15mL
HISTIDINE
4.9
mg/15mL
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
18.4
mg/15mL
HYALURONIDASE (HUMAN RECOMBINANT)
30000.0
U/15mL
METHIONINE
13.5
mg/15mL
POLYSORBATE 20
6.0
mg/15mL
SORBITOL
735.1
mg/15mL
57894-0503-01
1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE
May 1, 2020
Immunotherapy
Monoclonal Antibody
CD38
In Use